CN Patent

CN113660931A — 用于治疗皮肤癌的芳基苯胺和杂芳基苯胺化合物

Assigned to H Lee Moffett Cancer Center Institute · Expires 2021-11-16 · 5y expired

What this patent protects

本发明提供了用于治疗有需要的受试者的皮肤癌的化合物及其药物组合物,其中所述化合物为式(I)、(II)、(III)、(IV)和(V)中的任一种：其中，X 1 、X 2 、X 3 、R 1 、R 2 、R 2a 、R 13 、R 13a 、R 23 、R 23a 、R 23b 、R 33 、R 33a 、R 33b 、R 43 、R 43a 、R 51 、R 53 、R 53a 、R 53b 、键“a”和下标n如本文所述。

USPTO Abstract

本发明提供了用于治疗有需要的受试者的皮肤癌的化合物及其药物组合物,其中所述化合物为式(I)、(II)、(III)、(IV)和(V)中的任一种：其中，X 1 、X 2 、X 3 、R 1 、R 2 、R 2a 、R 13 、R 13a 、R 23 、R 23a 、R 23b 、R 33 、R 33a 、R 33b 、R 43 、R 43a 、R 51 、R 53 、R 53a 、R 53b 、键“a”和下标n如本文所述。

Drugs covered by this patent

Patent Metadata

Patent number
CN113660931A
Jurisdiction
CN
Classification
—
Expires
2021-11-16
Drug substance claim
No
Drug product claim
No
Assignee
H Lee Moffett Cancer Center Institute
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.